持田製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4534/E00947 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2015/06/26 | 日証協 | 122,764株 | -5.48% | 39,300株 | -26.93% | 90,838株 | -16.77% | 3,000株 | -78.26% |
| 2015/06/19 | 日証協 | 129,878株 | +4.15% | 53,787株 | +34.18% | 109,139株 | +9.21% | 13,800株 | -12.66% |
| 2015/06/12 | 日証協 | 124,703株 | +10.16% | 40,085株 | +8.02% | 99,939株 | -7.67% | 15,800株 | +25% |
| 2015/06/05 | 日証協 | 113,203株 | -13.39% | 37,108株 | -20.2% | 108,239株 | -8.82% | 12,640株 | +125.67% |
| 2015/05/29 | 日証協 | 130,703株 | 0% | 46,503株 | 0% | 118,706株 | 0% | 5,601株 | 0% |
| 2015/05/15 | 日証協 | 126,498株 | +13.45% | 16,092株 | -23.37% | 136,097株 | +2.94% | 11,000株 | +50.83% |
| 2015/05/08 | 日証協 | 111,498株 | -13.7% | 21,000株 | -40.41% | 132,206株 | -17.48% | 7,293株 | -63.73% |
| 2015/05/01 | 日証協 | 129,205株 | +17.19% | 35,240株 | +5.11% | 160,213株 | +9.28% | 20,108株 | +95.2% |
| 2015/04/24 | 日証協 | 110,250株 | +5.64% | 33,526株 | -19.42% | 146,606株 | +5.32% | 10,301株 | -33.94% |
| 2015/04/17 | 日証協 | 104,364株 | +13.45% | 41,606株 | +72.2% | 139,198株 | -1.21% | 15,593株 | +8.28% |
| 2015/04/10 | 日証協 | 91,993株 | -4.61% | 24,162株 | -24.48% | 140,905株 | +3.3% | 14,400株 | -65.96% |
| 2015/04/03 | 日証協 | 96,435株 | +33.32% | 31,993株 | -33.91% | 136,405株 | +13.1% | 42,298株 | +176.46% |
| 2015/03/20 | 日証協 | 104,367株 | +0.6% | 61,307株 | +888.82% | 148,320株 | -6.31% | 44,600株 | +528.17% |
| 2015/03/13 | 日証協 | 103,745株 | -6.66% | 6,200株 | -89.14% | 158,304株 | -2.28% | 7,100株 | -58.72% |
| 2015/03/06 | 日証協 | 111,145株 | -6.71% | 57,100株 | -3.02% | 162,004株 | +4.31% | 17,200株 | +855.56% |
| 2015/02/27 | 日証協 | 119,145株 | -24.11% | 58,878株 | +7.53% | 155,304株 | -17% | 1,800株 | +55.71% |
| 2015/02/20 | 日証協 | 156,999株 | +1.03% | 54,754株 | +629.08% | 187,105株 | -2.1% | 1,156株 | -87.7% |
| 2015/02/13 | 日証協 | 155,399株 | -0.82% | 7,510株 | -86.77% | 191,114株 | +0.21% | 9,400株 | +9.29% |
| 2015/02/06 | 日証協 | 156,689株 | -4.6% | 56,744株 | -16.52% | 190,714株 | -5.03% | 8,601株 | +258.38% |
※株式分割は考慮していませんのでご注意ください。
Page Top